Nurix Therapeutics, Inc.
NRIXNASDAQHealthcare● Active
$15.64
+$1.00(+6.83%)
Market Cap$1.4B
P/E Ratio—
52W High$22.5
52W Low$8.195
Nurix Therapeutics, Inc.（NRIX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · NRIX · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-11 | 2024-11 | 2023-11 | 2022-11 | 2021-11 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $83.98M | $54.55M | $76.99M | $38.63M | $29.75M |
| Cost of Revenue | $18.86M | $221.63M | $189.15M | $184.50M | $116.43M |
| Gross Profit | $65.12M | ($167.08M) | ($112.16M) | ($145.87M) | ($86.68M) |
| Gross Margin %(computed) | 77.55% | -306.30% | -145.69% | -377.64% | -291.37% |
| Operating Expenses | |||||
| R&D Expenses | $308.16M | $221.63M | $189.15M | $184.50M | $116.43M |
| G&A Expenses | $52.74M | $45.94M | $42.90M | $38.00M | $31.20M |
| Total Operating Expenses | $350.79M | $45.94M | $42.90M | $38.00M | $31.20M |
| Operating Income | ($285.67M) | ($213.03M) | ($155.06M) | ($183.87M) | ($117.89M) |
| Operating Margin %(computed) | -340.16% | -390.52% | -201.41% | -476.01% | -396.26% |
| Interest Income | $21.97M | $19.73M | $11.12M | $3.51M | $0.82M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($263.70M) | ($193.30M) | ($143.95M) | ($180.36M) | ($117.06M) |
| Income Tax Expense | $0.76M | $0.27M | $0.00M | $0.00M | $0.13M |
| Net Income | ($264.46M) | ($193.57M) | ($143.95M) | ($180.36M) | ($117.19M) |
| Net Margin %(computed) | -314.90% | -354.85% | -186.98% | -466.93% | -393.93% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.05 | $-2.88 | $-2.65 | $-3.71 | $-2.73 |
| Wtd Avg Shares | 86.67M | 67.12M | 54.34M | 48.61M | 42.90M |
| EBITDA | ($244.84M) | ($205.01M) | ($148.93M) | ($179.72M) | ($115.90M) |
| EBITDA Margin %(computed) | -291.55% | -375.83% | -193.45% | -465.27% | -389.57% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Nurix Therapeutics, Inc.
关于Nurix Therapeutics, Inc.（NRIX）损益表
Nurix Therapeutics, Inc.（NRIX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，NRIX实现营收$0.08B，毛利润$0.07B（毛利率77.55%），净利润($0.26B)（净利率-314.90%）。
常见问题
NRIX · 4 问Nurix Therapeutics, Inc.（NRIX）2025财年营收为$0.08B，同比up54.0%。
NRIX revenueNRIX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08